Trial intelligence / Profile preview

WRSS1 Vaccine in Healthy Thai Adults

NCT01080716Phase 2Completed

Sponsor
U.S. Army Medical Research and Development Command
Start
May 2010
Primary completion
Sep 2010
Modality
Live Attenuated Vaccines
Countries
1
01

Overview

A Phase 2 trial of shigella sonnei strain wrss1 vaccine in shigellosis, sponsored by U.S. Army Medical Research and Development Command. Started May 2010; status: completed.

02

Drugs

shigella sonnei strain wrss1 vaccine
03

Conditions

shigellosis

Beyond the preview

Go deeper on NCT01080716.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01080716.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call